Changes in the Brain Accumulation of Glucocorticoids in abcb1a-Deficient CF-1 Mice

Journal of Neuroendocrinology

Volumn 24, Issue 11, 2012, Pages 1440-1446

  Mason, B L ^a   Pariante, C M ^a   Thomas, S A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Blood brain barrier; Choroid plexus; Glucocorticoids; Hypothalamic pituitary adrenal axis; P glycoprotein

Indexed keywords

CORTICOSTERONE; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; ISOPROTEIN; MULTIDRUG RESISTANCE PROTEIN; PROTEIN ABCB1A; PROTEIN ABCB1B; UNCLASSIFIED DRUG;

ABCB1 GENE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BLOOD BRAIN BARRIER; BRAIN HOMOGENATE; BRAIN PERFUSION; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CHOROID PLEXUS; FRONTAL CORTEX; GENE; HIPPOCAMPUS; HYPOPHYSIS; HYPOTHALAMUS; IN VIVO STUDY; KNOCKOUT MOUSE; LIPOPHILICITY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SEQUENCE HOMOLOGY;

ANIMALS; BRAIN; BRAIN CHEMISTRY; CAPILLARIES; CHOROID PLEXUS; CORTICOSTERONE; DEXAMETHASONE; GLUCOCORTICOIDS; HYDROCORTISONE; MALE; MICE; MICE, KNOCKOUT; P-GLYCOPROTEINS; PITUITARY GLAND;

EID: 84867685385     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2012.02353.x     Document Type: Article

References (40)

1. Schinkel AH. P-glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Deliv Rev 1999; 36: 179-194.
2. Athauda SBP, Athauda NKRB, Crane A, Ridlon A, Segal MB, Preston JE. Blood-brain barrier transfer of corticosterone in normal and protein deprived rats. Role of multi-drug resistance protein efflux. Abstract for The Physiological Society Meeting. University of Cambridge Communications. 2004; p555.
3. Cordon-Cardo C, O'Brien JP, Casels D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 1989; 86: 695-698.
4. Croop JM, Raymond M, Haber D, Devault A, Arceci RJ, Gros P, Housman DE. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol Cell Biol 1989; 9: 1346-1350.
5. Schinkel AH, Mayer U, Wagenaar E, Mol CA, van Deemter L, Smit JJ, van der Valk MA, Voordouw AC, Spits H, van Tellingen O, Zijlmans JM, Fibbe WE, Borst P. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA 1997; 94: 4028-4033.
6. Borst P, Schinkel AH. What have we learnt thus far from mice with disrupted P-glycoprotein genes?Eur J Cancer 1996; 32A: 985-990.
7. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissue. Proc Natl Acad Sci USA 1987; 84: 7735-7738.
8. Devault A, Gros P. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol Cell Biol 1990; 10: 1652-1663.
9. Jetté L, Béliveau R. P-glycoprotein is strongly expressed in brain capillaries. Adv Exp Med Biol 1993; 331: 121-125.
10. Cisternino S, Rousselle C, Debray M, Scherrmann JM. In situ transport of vinblastine and selected P-glycoprotein substrates: implications for drug-drug interactions at the mouse blood-brain barrier. Pharm Res 2004; 21: 1382-1389.
11. Sun H, Dai H, Shaik N, Elmquist WF. Drug efflux transporters in the CNS. Adv Drug Deliv Rev 2003; 55: 83-105.
12. Yousif S, Marie-Claire C, Roux F, Scherrmann JM, Declèves X. Expression of drug transporters at the blood-brain barrier using an optimized isolated rat brain microvessel strategy. Brain Res 2007; 1134: 1-11.
13. Regina A, Koman A, Piciotti M, El Hafny B, Center MS, Bergmann R, Couraud PO, Roux F. Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J Neurochem 1998; 71: 705-715.
14. Barrand MA, Robertson KJ, von Weikersthal SF. Comparisons of P-glycoprotein expression in isolated rat brain microvessels and in primary cultures of endothelial cells derived from microvasculature of rat brain, epididymal fat pad and from aorta. FEBS Lett 1995; 374: 179-183.
15. Kwan P, Sills GJ, Butler E, Gant TW, Brodie MJ. Differential expression of multidrug resistance genes in naïve rat brain. Neurosci Lett 2003; 339: 33-36.
16. Karssen AM, Meijer OC, Pons D, de Kloet ER. Localization of mRNA expression of P-glycoprotein at the blood-brain barrier and in the hippocampus. Ann NY Acad Sci 2004; 1032: 308-311.
17. Choudhuri S, Cherrington NJ, Li N, Klaassen CD. Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats. Drug Metab Dispos 2003; 31: 1337-1345.
18. Kassem NA, Deane R, Segal MB, Chen R, Preston JE. Thyroxine (T4) transfer from CSF to choroid plexus and ventricular brain regions in rabbit: contributory role of P-glycoprotein and organic anion transporting polypeptides. Brain Res 2007; 1181: 44-50.
19. Rao VV, Dahlheimer JL, Bardgett ME, Snyder AZ, Finch RA, Sartorelli AC, Piwnica-Worms D. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal fluid drug-permeability barrier. Proc Natl Acad Sci USA 1999; 96: 3900-3905.
20. Gazzin S, Strazielle N, Schmitt C, Fevre-Montange M, Ostrow JD, Tiribelli C, Ghersi-Egea J-F. Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces. J Comp Neurol 2008; 510: 497-507.
21. Karssen AM, Meijer OC, van der Sandt IC, Lucassen PJ, de Lange EC, de Boer AG, de Kloet ER. Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. Endocrinology 2001; 142: 2686-2694.
22. Mark PJ, Waddell BJ. P-glycoprotein restricts the access of cortisol and dexamethasone to the glucocorticoid receptor in placental BeWo cells. Endocrinology 2006; 147: 5147-5152.
23. Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, Komano T, Hori R. Human P-glycoprotein transporters cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem 1992; 267: 24248-24252.
24. van Kalken CK, Broxterman HJ, Pinedo HM, Feller N, Dekker H, Lankelma J, Giaccone G. Cortisol is transported by the multidrug resistance gene product P-glycoprotein. Br J Cancer 1993; 67: 284-289.
25. Wolf DC, Horwitz SB. P-glycoprotein transports corticosterone and is photoaffinity-labeled by the steroid. Int J Cancer 1992; 52: 141-146.
26. Gruol DJ, Vo QD, Zee MC. Profound differences in the transport of steroids by two mouse P-glycoproteins. Biochem Pharmacol 1999; 58: 1191-1199.
27. Meijer OC, de Lange EC, Breimer DD, de Boer AG, Workel JO, de Kloet ER. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 1998; 139: 1789-1793.
28. Uhr M, Holsboer F, Müller MB. Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins. J Neuroendocrinol 2002; 14: 753-759.
29. Müller MB, Keck ME, Binder EB, Kresse AE, Hagemeyer TP, Landgraf R, Holsboer F, Uhr M. ABCB1 (MDR1)-type P-glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary-adrenocortical system: implications for affective disorder. Neuropsychopharmacology 2003; 28: 1991-1999.
30. Yau JL, Noble J, Thomas S, Kerwin R, Morgan PE, Lightman S, Seckl JR, Pariante CM. The antidepressant desipramine requires the ABCB1 (Mdr1)-type p-glycoprotein to upregulate the glucocorticoid receptor in mice. Neuropsychopharmacology 2007; 32: 2520-2529.
31. Mason BL, Pariante CM, Jamel S, Thomas SA. Central nervous system (CNS) delivery of glucocorticoids is fine-tunes by saturable transporters at the blood-CNS barriers and nonbarrier regions. Endocrinology 2010; 151: 5294-5305.
32. Mason BL, Pariante CM, Thomas SA. A revised role for P-glycoprotein in the brain distribution of dexamethasone, cortisol, and corticosterone in wild type and abcb1a/b-deficient mice. Endocrinology 2008; 149: 5244-5253.
33. Sanderson L, Khan A, Thomas SA. Distribution of suramin, an antitrypanosomal drug, across the blood-brain and blood-cerebrospinal fluid interfaces in wild-type and P-glycoprotein transporter-deficient mice. Antimicrob Agents Chemother 2007; 51: 3136-3146.
34. Triguero D, Buciak J, Pardridge WM. Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J Neurochem 1990; 54: 1882-1888.
35. Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CA, van der Valk MA, Robanus-Maandag EC, te Riele HP, Berns AJM, Borst P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994; 77: 491-502.
36. Suzuyama N, Katoh M, Takeuchi T, Yoshitomi S, Higuchi T, Asashi S, Yokoi T. Species differences of inhibitory effects on P-glycoprotein-mediated drug transport. J Pharma Sci 2007; 96: 1609-1618.
37. Garrigues A, Loiseau N, Delaforge M, Ferté J, Garrigos M, André F, Orlowski S. Characterization of two pharmacophores on the multidrug transporter P-glycoprotein. Mol Pharmacol 2002; 62: 1288-1298.
38. Loo TW, Clarke DM. Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux. J Membr Biol 2005; 206: 173-185.
39. Pavek P, Merino G, Wagenaar E, Bolscher E, Novatna M, Jonker JW, Schinkel AH. Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine, and transport of cimetidine. J Pharmacol Exp Ther 2005; 312: 144-152.
40. Soontornmalai A, Vlaming ML, Fritschy JM. Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood-brain barrier. Neuroscience 2006; 138: 159-169.